Opiant Pharmaceuticals to Hold Virtual 2022 Annual Shareholder Meeting on Tuesday, June 14, 2022 at 9:00am PDT
May 20 2022 - 4:05PM
Opiant Pharmaceuticals, Inc. (“Opiant”) (NASDAQ: OPNT),
announced today that to protect the health and safety of its
shareholders, employees, and communities amidst a rise locally in
COVID-19, Opiant's 2022 Annual Meeting of Shareholders will be held
in a virtual-only meeting format via live audio webcast. The
meeting will be held online only and will begin at 09:00 AM PDT on
June 14, 2022, as previously scheduled. The matters to be voted on
at the 2022 Annual Meeting, remain unchanged.
The Company’s proxy statement describing the formal business to
be conducted at the meeting is available on the Investors section
of the Company’s website at:
https://ir.opiant.com/static-files/2112e0ec-9025-42f9-9204-084a734d662b
Shareholders who elect to virtually attend the meeting may do so
as follows:
Date: Tuesday, June 14, 2022Time: 9:00 a.m. (PDT)Live
Virtual Meeting: https://zoom.us/j/95041888598 (Meeting
ID: 950 4188 8598)
Find your local number via https://zoom.us/u/apRdfUhqI
Shareholders of record at the close of business on April
18, 2021, the record date for the 2022 Annual Meeting, are entitled
to participate in the virtual meeting and will need their assigned
16-digit control number to vote shares electronically at the
virtual meeting by submitting an email to:
Admin12@astfinancial.com
Important Information for Voting Shares
Your vote is important. Whether or not shareholders plan to
attend the virtual-only annual meeting, Opiant urges shareholders
to vote and submit their proxies in advance of the meeting by one
of the methods described in the proxy materials.
Shareholders of record with Internet access may submit proxies
until 11:59 p.m., Eastern Time, on June 14, 2022, by following the
instructions on your proxy cards or at www.voteproxy.com.
Shareholders who have already voted their shares do not need to
vote them again because of this change in meeting format.
A list of shareholders entitled to vote at the 2022 Annual
Meeting will be available for review by interested shareholders.
Please contact the Company’s Investor Relations by sending an
e-mail to batkins@opiant.com, if you wish to inspect the list
prior to the meeting.
Attending the Annual Meeting as a Guest
Those without a control number may attend the virtual meeting as
guests, but will not have the option to vote.
About Opiant Pharmaceuticals, Inc.Opiant
Pharmaceuticals, Inc., the company that developed NARCAN® Nasal
Spray, is building a leading franchise of new medicines
to combat addictions and drug overdose.For more information
visit: www.opiant.com.
Investor Relations Contacts:
Ben AtkinsVP of Corporate Communications and
Investor RelationsBatkins@opiant.com(310) 598-5410
Opiant Pharmaceuticals (NASDAQ:OPNT)
Historical Stock Chart
From Mar 2024 to Apr 2024
Opiant Pharmaceuticals (NASDAQ:OPNT)
Historical Stock Chart
From Apr 2023 to Apr 2024